ClinicalTrials.govpublic full text
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
mild cognitive impairment (mci) due to alzheimer's disease, alzheimer's disease, mild cognitive impairment, clinical trial, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1031410
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.